Fetzima Approval History

  • FDA approved: Yes (First approved July 25th, 2013)
  • Brand name: Fetzima
  • Generic name: levomilnacipran
  • Company: Forest Laboratories, Inc. and Pierre Fabre Laboratories
  • Treatment for: Depression, Major Depressive Disorder

Fetzima (levomilnacipran) is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of major depressive disorder.

FDA Approval History for Fetzima

DateArticle
Jul 26, 2013Approval Forest Laboratories and Pierre Fabre Laboratories Announce FDA Approval of Fetzima for the Treatment of Major Depressive Disorder in Adults
Sep 27, 2012Forest Laboratories Submits New Drug Application for Levomilnacipran for the Treatment of Major Depressive Disorder

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)